Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/21/2005EP1605919A1 Stable pharmaceutical composition of rabeprazole and processes for their preparation
12/21/2005EP1605918A2 Novel galenical system for active transport, method for preparation and use
12/21/2005EP1605917A1 Process for the production of cross-linked gelatin microbeadlets
12/21/2005EP1605916A1 Solvent system of hardly soluble drug with improved elution rate
12/21/2005EP1605915A2 Methods and apparatuses for the comminution and stabilization of small particles
12/21/2005EP1605914A1 Method for preparing small particles
12/21/2005EP1605913A2 Angiogenesis promotion by prostaglandin compositions and methods
12/21/2005EP1605912A2 Preserved ophthalmic compositions
12/21/2005EP1605900A2 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
12/21/2005EP1605895A2 Oral insulin therapies and protocol
12/21/2005EP1605894A2 Oxytocin controlled release formulations and methods of using same
12/21/2005EP1605863A2 Sinus delivery of sustained release therapeutics
12/21/2005EP1465665B1 Water-soluble stabilized self-assembled polyelectrolytes
12/21/2005EP1443968A4 Edible film
12/21/2005EP1429780B1 Method of treating middle ear infections
12/21/2005EP1421168B1 Concentrated stock of capsules for detergent or personal care compositions
12/21/2005EP1282429A4 Pharmaceutical gel composition
12/21/2005EP1282402B1 Stabilized aqueous suspensions for parenteral use
12/21/2005EP1250161B1 Polymer blends as biodegradable matrices for preparing biocomposites
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1213974B1 Directly compressable raw material for tablets
12/21/2005EP1180015B1 Generation of therapeutic microfoam
12/21/2005EP1150703B1 Chaperonin 10 and beta-interferon therapy of multiple sclerosis
12/21/2005EP1023059B1 Pharmaceutical preparations
12/21/2005EP0883462B1 Laser drilling process for producing a plurality of holes in chemical dosage forms using acousto-optic deflector
12/21/2005EP0809705B1 Nucleic acid-containing composition, preparation and use thereof
12/21/2005EP0785772A4 Lyophilizate of lipid complex of water insoluble camptothecins
12/21/2005CN1711104A An aqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboemb
12/21/2005CN1711103A Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
12/21/2005CN1711096A Botulinum toxin formulations for oral administration
12/21/2005CN1711093A Process to minimize loss through adhesion to equipment surfaces
12/21/2005CN1711092A The use of an anti-allergy agent and a steroid to treat allergic rhinitis
12/21/2005CN1711077A Combination product for controlling insect pests
12/21/2005CN1711074A Liposomes
12/21/2005CN1711073A Medicine composition containing octreotide grains
12/21/2005CN1711072A Multi-layer transmucosal therapeutic system
12/21/2005CN1709426A Capsule for treating hypertension and coronary disease and its preparing method
12/21/2005CN1709245A Use of levo-ornidazole for preparing anti-parasitic-infectious drug
12/21/2005CN1709226A Magnetic-control pulse administrating cataplasm and its manufacturing method
12/21/2005CN1709225A Method for preparing health-care foods for auxiliary inhibiting tumour using polygonum cuspidatum extract
12/21/2005CN1709224A Method for preparing polymer magnetic drug-carrying particle using supercritical Co2 anti-dissolving agent process
12/21/2005CN1709223A Material gradient controlled-release administrating system and its three-dimensional printing-forming preparation method
12/21/2005CN1709222A Gastric floating slow-release administrating system and its three-dimensional printing forming preparation method
12/21/2005CN1232623C Method for moistening contact lens and low ionic strength ophthalmic compositions used therefor
12/21/2005CN1232600C Film coating material
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232339C Mixing apparatus
12/21/2005CN1232316C Auxiliary device for sticking pasting agent
12/21/2005CN1232299C Chinese medicinal composition for treating liver cancer
12/21/2005CN1232296C Chinese herbal medicinal preparation for curing sinew bone disease
12/21/2005CN1232295C White flagger oral liquid and its preparing method
12/21/2005CN1232294C Externally applied Chinese medicinal composition for treating onychomycosis and its preparing process
12/21/2005CN1232292C Chinese medicine for treating prostatitis
12/21/2005CN1232291C Medicine for treating diabetes
12/21/2005CN1232289C Medicine for treating cranial vascular disease
12/21/2005CN1232288C Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process
12/21/2005CN1232285C Chinese Medicine for treating cervical vertebra disease and its preparation method
12/21/2005CN1232283C Chinese drugs for treatment of coronary heart disease and angina pectoris
12/21/2005CN1232262C Eyedrop powder for treating palsy
12/21/2005CN1232261C Peritoneal dialysates and its preparing method
12/21/2005CN1232259C Medicine composition with two-way immune regulation function by oral cavity local administration
12/21/2005CN1232254C United slow release agent for preventing and treating piglet and rabbit coccidiosis and dysentery disease and its preparing method
12/21/2005CN1232253C Combined slow-release agent for preventing and treating domestic animal schistosome, fascioliasis, cestodiasis and nematodiasis disease and preparing method thereof
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232251C Gingko lactone powder injection and its preparation method
12/21/2005CN1232250C Andrographolide lactone microcapsule and its preparation method
12/21/2005CN1232248C Combined sustained release agent and preparation thereof for preventing and treating livestock helminth, acarid and ectosarc disease
12/21/2005CN1232245C Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same
12/21/2005CN1232244C Stable non-aqueous single phase viscose carrier and formulations utilizing such carrier
12/21/2005CN1232184C Immunity-regulating and fatigue-resisting capsule preparation
12/21/2005CA2510887A1 A method for treating inflammatory bowel disease by oral administration of il-10
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977257 Aripiprazole oral solution
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977249 molecular weight reduction of dextran by hydrolysis, hydrogenation, and oxidation; complexing with ferric oxy-hydroxide; narrow molecular weight distribution controlled by the ratio of hydrogenated/oxygenated groups; improved stability; anemia
12/20/2005US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
12/20/2005US6977244 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/20/2005US6977243 Crystal forms of azithromycin
12/20/2005US6977171 Detoxification and decontamination using nanotechnology therapy
12/20/2005US6977087 Administering to the respiratory system of a patient or animal hormone aerodynamically light particles, wherein particles are delivered and deposited to patient's or animal's lungs and hormone is released in patient's or animal's blood stream
12/20/2005US6977086 with improved strawberry and creamy flavoring; dry powder form; organoleptics; increased shelf life; pediatrics
12/20/2005US6977085 Dissolving first quantity of pharmaceutically-active compound in water-miscible first organic solvent to form a first solution; mixing first solution with second solvent to precipitate pharmaceutically-active compound; seeding
12/20/2005US6977083 Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
12/20/2005US6977081 an emollient cream of sulfur, sodium sulfacetimide, allantoin, water, sodium thiosulfate, methyl paraben, propylene glycol, stearic acid, PEG-8 stearate, emulsifying wax, isopropyl myristate, propylene glycol stearate, propyl paraben; pH of 7
12/20/2005US6977074 to an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
12/20/2005US6977070 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
12/20/2005US6976983 use of helical winding for all embodiments of invention results in simple helical wire wrap that creates very long orifice and results in primary benefits such as simplicity, compactness, readily adaptable and customizable design, low cost
12/20/2005US6976982 Flexible microchip devices for ophthalmic and other applications
12/20/2005US6976981 Osmotic delivery system with membrane plug retention mechanism
12/20/2005CA2322432C Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
12/20/2005CA2290966C Sertraline salts and sustained-release dosage forms of sertraline
12/20/2005CA2275593C Micro-particulate form of a tetrahydropyridin derivative
12/20/2005CA2199778C Extended release formulation of venlafaxine
12/20/2005CA2130305C Distribution device for a therapeutical or cosmetic substance on a volatile polydiorganosiloxane inert carrier; composition usable in said device
12/18/2005CA2509927A1 Solid dosage form for acid-labile active ingredient
12/18/2005CA2504471A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/17/2005CA2498169A1 Coating process and apparatus with improved resistance to bacteria
12/15/2005WO2005119610A1 Communication unit for a person's skin
12/15/2005WO2005118702A2 Unagglomerated core/shell nanocomposite particles
12/15/2005WO2005118672A1 Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
1 ... 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 ... 2991